跳至主要内容
临床试验/NCT02031887
NCT02031887终止不适用

Effect of a Starter Formula With Synbiotics on Stool Microbiota in Infants After Normal or Caesarean Section Delivery

Société des Produits Nestlé (SPN)6 个研究点 分布在 1 个国家目标入组 430 人开始时间: 2008年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
430
试验地点
6
主要终点
differences in the colonization of the gastrointestinal tract with the bacteria Bifidobacterium sp. between infants born by normal or caesarean delivery, fed with the test or a control product

研究概览

简要总结

The primary objectives of this trial are:

  • to show differences in the colonization of the gastrointestinal tract with the bacteria Bifidobacterium sp. between infants born by normal or caesarean delivery, fed with the test or a control product
  • to investigate whether there is equivalence in growth between the four different groups of infant described above.

详细描述

The primary objectives of this trial are:

  • to show differences in the colonization of the gastrointestinal tract with the bacteria Bifidobacterium sp. between infants born by normal or caesarean delivery, fed with the test or a control product
  • to investigate whether there is equivalence in growth between the four different groups of infant described above.

Design:

This is a controlled, double blind, randomized, multi center, clinical trial of 4 groups in parallel.

Two groups of infants (born from normal or caesarean delivery) will each consume one of 2 milk formulae.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 3 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Healthy newborn infant from HIV positive mother
  • Full term infant (more or equal to 37 weeks gestation; less or equal to 42 weeks gestation)
  • Age of infant 3 days at the time of enrollment
  • Birth weight between 2500 and 4500 grams
  • Singleton birth
  • The infant's mother has elected to feed their child exclusively with a milk formula from birth
  • Informed consent from the parent or legal guardian

排除标准

  • Congenital illness or malformation that may affect normal growth
  • Significant pre-natal and / or post-natal disease
  • Newborns who have received antibiotics during the first 3 days of life
  • Newborns whose parents / caregivers cannot be expected to comply with the study protocol
  • Newborns currently participating in another clinical trial

结局指标

主要结局

differences in the colonization of the gastrointestinal tract with the bacteria Bifidobacterium sp. between infants born by normal or caesarean delivery, fed with the test or a control product

时间窗: 3 days, 10 days, 1 month, and 3 months of age of the infant

• Mean weight gain (g/day)

时间窗: over 112 days

次要结局

  • body composition by DEXA(4 month and 12 month of life)
  • Digestive tolerance (stool characteristics and frequency, vomiting, regurgitation, frequency of colic)(10 days, 1 month, 6 weeks, 3 month and 4 month of life)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Effect of a Starter Formula With Synbiotics on Stool... | 临床试验